
1. clin liver dis. 2010 feb;14(1):75-91; viii-ix. doi: 10.1016/j.cld.2009.11.013.

management acute hepatitis b.

shiffman ml(1).

author information: 
(1)bon secours health system, liver institute virginia, richmond, va, usa.
mlshiffman@gmail.com

acute hepatitis b virus (hbv) common cause acute icteric hepatitis in
adults. vast majority patients resolve acute infection and
develop long-lasting immunity. contrast, vast majority patients who
develop chronic hbv minimal symptoms develop jaundice after
becoming infected hbv. patients frequently remain undiagnosed for
years decades. approximately 1% persons acute hbv develop acute liver 
failure. preventing acute hbv vaccination best treatment. although
universal vaccination administered newborns many countries, the
majority adults vaccinated remain risk. the
majority patients acute hbv resolve infection spontaneously,
treatment oral anti-hbv agent necessary. however, use an
oral anti-hbv agent unreasonable use patient developing
acute liver failure severe acute hbv.

(c) 2010 elsevier inc. rights reserved.

doi: 10.1016/j.cld.2009.11.013 
pmid: 20123442  [indexed medline]

